Regarding the acute toxicity and management of heavy metal poisoning, all of the following statements are correct EXCEPT:

Explanation

## Heavy Metal Poisoning: Mechanisms and Management ### Lead Poisoning and Basophilic Stippling **Key Point:** Lead inhibits pyrimidine 5'-nucleotidase, preventing degradation of RNA. This causes accumulation of ribosomes and RNA in RBCs, visible as basophilic stippling on blood smear. This statement is **TRUE** and is a classic, high-yield finding in lead poisoning. ### Mercury Poisoning and Acrodynia **Key Point:** Acrodynia (pink disease) IS a well-recognized syndrome associated with mercury exposure — historically from mercurial teething powders and ointments. It is characterized by painful, erythematous extremities, hyperhidrosis, irritability, and psychological disturbances. This association is well-established in toxicology literature. This statement is **TRUE**. ### Thallium Toxicity and Prussian Blue — The Correct Exception **High-Yield:** Prussian blue (ferric ferrocyanide) IS the standard treatment for thallium poisoning. However, the mechanism described in option C is **INCORRECT**. Prussian blue works by **ion exchange in the gastrointestinal tract** — it binds thallium (and cesium) within the gut lumen, preventing reabsorption and increasing fecal elimination. It does **NOT** work by affecting enterohepatic circulation per se; rather, it acts as an ion exchanger that traps thallium secreted into the intestine, thereby interrupting the enterohepatic cycle by preventing reabsorption. The statement that it "increases fecal elimination via enterohepatic circulation" misrepresents the mechanism — the drug's action is ion exchange/adsorption in the gut, not a pharmacokinetic manipulation of enterohepatic circulation. This makes option C the **INCORRECT** statement. **Clinical Pearl:** Prussian blue is FDA-approved for thallium and radioactive cesium poisoning. Its mechanism is ion exchange in the gut lumen, not modulation of enterohepatic circulation. ### Cadmium Toxicity **Key Point:** Cadmium accumulates preferentially in the kidneys (bound to metallothionein) and causes proximal tubular damage, leading to low-molecular-weight proteinuria, glucosuria, aminoaciduria (Fanconi syndrome pattern), and progressive chronic kidney disease (Itai-itai disease in chronic exposure). This statement is **TRUE**. ### Summary Table | Heavy Metal | Characteristic Finding | Management | |---|---|---| | Lead | Basophilic stippling, encephalopathy, neuropathy | EDTA, DMSA (succimer) | | Mercury | Acrodynia (chronic/low-level), Minamata disease (organic) | BAL, supportive care | | Thallium | Alopecia, GI symptoms, peripheral neuropathy | Prussian blue (ion exchange in gut) | | Cadmium | Renal tubular damage, proteinuria, Itai-itai disease | Supportive; DMSA | **Key Point:** Option C is the EXCEPT answer because while Prussian blue IS the correct treatment for thallium, the stated mechanism ("via enterohepatic circulation") is inaccurate — the correct mechanism is ion exchange/adsorption within the GI tract. [cite: KD Tripathi Essentials of Medical Pharmacology 8e; Casarett and Doull's Toxicology 9e Ch 23; Parikh Textbook of Forensic Medicine Ch 15]